SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Smith JA Jr, Labasky RF, Cockett AT, Fracchia JA, Montie JE, Rowland RG. Bladder cancer clinical guidelines panel summary report on the management of non-muscle invasive bladder cancer (stages Ta, T1 and Tis). The American Urological Association. J Urol 1999; 162: 1697701
  • 2
    Klän R, Loy V, Huland H. Residual tumor discovered in routine second TUR in patients with T1 transitional cell carcinoma of the bladder. J Urol 1991; 146: 3168
  • 3
    Herr H. The value of a second transurethral resection in evaluating patients with bladder tumours. J Urol 1999; 162: 746
  • 4
    Köhrmann KU, Woeste M, Kappes J, Rassweiler J, Alken P. Der Wert der transurethralen nachresektion beim oberflächlichen harnblasenkarzinom. Akt Urol 1994; 25: 20811
  • 5
    Vögeli TA, Grimm M, Ackermann R. Prospective study for quality control of TUR of bladder tumours by routine second TUR (reTUR). J Urol 1998; 159 (Suppl): A543
  • 6
    Mersdorf A, Brauers A, Wolf JM, Schneider V, Jakse G. Second TUR for superficial bladder cancer: A must? J Urol 1998; 159 (Suppl): A542
  • 7
    Brauers A, Buettner R, Jakse G. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? J Urol 2001; 165: 80810
  • 8
    Engelhardt PF, Simak R, Riedl CR, Pflüger H. Is a second look TUR-B in patients with superficial bladder cancer necessary? Eur Urol 1999; 35: A93
  • 9
    Schips L, Augustin H, Zigeuner RE et al. Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer? Urology 2002; 59: 2203
  • 10
    Grimm MO, Steinhoff C, Simon X, Spiegelhalder P, Ackermann R, Vögeli TA. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 2003; 170: 4337
  • 11
    Zurkirchen MA, Sulser T, Gaspert A, Hauri D. Second transurethral resection of superficial transitional cell carcinoma of the bladder: a must even for experienced urologists. Urol Int 2004; 72: 99102
  • 12
    Vögeli TA, Thiel R, Grimm M, Ackermann R. Does urine cytology contribute to decision making for reTUR of transitional cell carcinoma of the bladder? J Urol 1997; 157 (Suppl): A1479
  • 13
    Miladi M, Peyromaure M, Zerbib M, Saighi D, Debre B. The value of a second transurethral resection in evaluating patients with bladder tumours. Eur Urol 2003; 43: 2415
  • 14
    Jakse G, Algaba F, Malmström PU, Oosterlinck W. A second look TUR in T1 transitional cell carcinoma: why? Eur Urol 2004; 45: 53946
  • 15
    Kriegmair M, Zaak D, Rothenberger KH et al. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. J Urol 2002; 168: 4758
  • 16
    Oosterlinck W, Lobel B, Jakse G, Malmstrom PU, Stockle M, Sternberg C; European Association of Urology (EAU) Working Group on Oncological Urology. Guidelines on bladder cancer. Eur Urol 2002; 41: 10512